Literature DB >> 12794579

Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study.

Dagny Ståhlberg1, Béla Veress, Bernhard Tribukait, Ulrika Broomé.   

Abstract

INTRODUCTION: Patients with ulcerative colitis and primary sclerosing cholangitis have an increased risk of developing carcinoma both in the bile ducts and in the colon.
PURPOSE: To investigate whether this patient group also has an increased risk of developing atrophy and neoplasia in the ileal pouch mucosa after construction of a pelvic pouch with an ileoanal anastomosis or a continent Kock ileostomy.
METHODS: Flexible video endoscopic examinations of the ileal pouch were performed in 16 patients with ulcerative colitis and primary sclerosing cholangitis and in 16 matched patients with ulcerative colitis without sclerosing cholangitis. Biopsies were sampled from different locations in the pouch for histologic assessment of mucosal atrophy and dysplasia and for flow cytometric DNA analysis assessing chromosomal aberrations.
RESULTS: The patients with sclerosing cholangitis developed moderate or severe atrophy in the pouch significantly more often (P < 0.01). Persistent severe mucosal atrophy was revealed in eight patients with sclerosing cholangitis and only in two controls. One patient with sclerosing cholangitis had high-grade dysplasia in multiple locations. Low-grade dysplasia was assessed in three patients with sclerosing cholangitis and in two of the controls. DNA aneuploidy was displayed in three patients, all with sclerosing cholangitis and dysplasia. All patients with neoplastic transformation had a pouch with ileoanal anastomosis and a long pouch duration (> 8 years).
CONCLUSION: Patients with ulcerative colitis and primary sclerosing cholangitis with an ileal reservoir are more prone to developing mucosal atrophy in the pouch and seem to have a higher risk of neoplastic transformation in the pouch mucosa than patients with ulcerative colitis without sclerosing cholangitis.

Entities:  

Mesh:

Year:  2003        PMID: 12794579     DOI: 10.1007/s10350-004-6655-5

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  16 in total

Review 1.  The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis.

Authors:  Monira Rahman; Paul Desmond; Neil Mortensen; Roger W Chapman
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

2.  Adenocarcinoma of the ileoanal pouch for ulcerative colitis--a complication of severe chronic atrophic pouchitis?

Authors:  N Knupper; E Straub; H J Terpe; K H Vestweber
Journal:  Int J Colorectal Dis       Date:  2005-12-20       Impact factor: 2.571

Review 3.  Pouch-related dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis.

Authors:  J W Um; A E M'Koma
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

Review 4.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

5.  Hepatopancreatobiliary manifestations of inflammatory bowel disease.

Authors:  Kazuhiko Nakamura; Tetsuhide Ito; Kazuhiro Kotoh; Eikichi Ihara; Haruei Ogino; Tsutomu Iwasa; Yoshimasa Tanaka; Yoichiro Iboshi; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2012-01-06

6.  Clinical significance of indefinite for dysplasia on pouch biopsy in patients with underlying inflammatory bowel disease.

Authors:  Zhao-Xiu Liu; Xiu-Li Liu; Deepa T Patil; Lei Lian; Ravi P Kiran; Feza H Remzi; Run-Zhou Ni; Bo Shen
Journal:  J Gastrointest Surg       Date:  2011-11-29       Impact factor: 3.452

Review 7.  Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.

Authors:  Christos Tsaitas; Anysia Semertzidou; Emmanouil Sinakos
Journal:  World J Hepatol       Date:  2014-04-27

Review 8.  Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Authors:  María Rojas-Feria; Manuel Castro; Emilio Suárez; Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

9.  Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease.

Authors:  Hong Zhu; Xian-rui Wu; Elaine Queener; Ravi P Kiran; Feza H Remzi; Bo Shen
Journal:  Surg Endosc       Date:  2013-07-23       Impact factor: 4.584

Review 10.  Primary sclerosing cholangitis: diagnosis and management.

Authors:  Phunchai Charatcharoenwitthaya; Keith D Lindor
Journal:  Curr Gastroenterol Rep       Date:  2006-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.